The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (8.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.20
AEX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Placing to Fund Aminex to First Gas

1 Apr 2022 11:09

RNS Number : 9657G
Aminex PLC
01 April 2022
 

1 April 2022

 

Aminex plc

("Aminex" or "the Company")

 

Successful Placing to fund Aminex to First Gas Production

 

The Company is pleased to announce that it has successfully raised approximately £3.3 million (approximately $4.4 million) before expenses to fund the Company to the expected receipt of revenue from first gas production at the Ntorya field, currently projected for end of 2024, through the issue of 440,482,181 new ordinary shares in the capital of Aminex (the "Placing") at a price of Stg 0.75p per share (the "Placing Shares").

The board of Aminex has taken the strategic decision to seek funds at this stage to meet all of its forecasted running costs (before contingent liabilities) to the end of 2024, when first gas has been targeted by the operator of the Ruvuma PSA, ARA Petroleum Tanzania Limited ("APT"). As previously announced, the Company has continued to reduce its overheads over the last three years and the Company's estimated running costs for 2022 (before one-off costs and exceptional items) are approximately US$1.4 million.

The Placing Shares will represent in aggregate 12% of the existing issued ordinary share capital of the Company and are being issued under existing general allotment authorities granted by shareholders at the Company's Annual General Meeting on 29 July 2021. The Company's largest shareholder, Eclipse Investments LLC ("Eclipse"), will subscribe for 84,375,514 Placing Shares.

Application will be made to the Financial Conduct Authority for the Placing Shares to be admitted to the Official Lists and application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on the main market (standard segment) of the London Stock Exchange. It is expected that such admission will become effective and that dealings will commence in the Placing Shares at 8.00 a.m. (London time) on 19 April 2022. Following admission, the enlarged share capital and the total voting rights of the Company will be 4,211,167,024.

Charlie Santos, Executive Chairman of Aminex commented:

"This fully subscribed placement represents an important development for the Company and is an essential pillar in our effort to de-risk and anchor value. The funds ensure a solid financial foundation for the Company through to the expected commencement of cash flow receipts from Ruvuma. We look forward to the completion of the 3D seismic survey and the drilling of the Chikumbi-1 well later this year. We are thankful for the participation of all the investors, including our largest shareholder, Eclipse."

 

 

 

 

 

The information contained within this announcement is considered to be inside information prior to its release, as defined in Article 7 of the Market Abuse Regulation No. 596/2014, and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

For further information:

 

Aminex PLC

+44 203 355 9909

Charles Santos, Executive Chairman

Shard Capital Partners

+44 207 186 9952

Damon Heath

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBGGDSRGGDGDB
Date   Source Headline
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension
28th Nov 20227:00 amRNSRuvuma Commercial Update
1st Nov 202211:05 amRNSSecond Price Monitoring Extn
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20229:05 amRNSSecond Price Monitoring Extn
1st Nov 20229:00 amRNSPrice Monitoring Extension
1st Nov 20227:23 amRNSRuvuma Operations Update
6th Oct 20224:41 pmRNSSecond Price Monitoring Extn
6th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNS2022 Half-Yearly Financial Report
1st Sep 202210:59 amRNSRuvuma PSA
1st Sep 20227:00 amRNSRuvuma Seismic and Commercial Update
18th Aug 20222:05 pmRNSSecond Price Monitoring Extn
18th Aug 20222:00 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSKiliwani Operations Update
1st Aug 20227:00 amRNSStrategy/Company/Ops Update
13th Jul 20224:23 pmRNSRuvuma PSA
6th Jun 20222:06 pmRNSSecond Price Monitoring Extn
6th Jun 20222:00 pmRNSPrice Monitoring Extension
1st Jun 20223:41 pmRNSTotal Voting Rights
26th May 20224:04 pmRNSResult of AGM
4th May 20227:00 amRNSNotice of AGM
11th Apr 20227:00 amRNSFinal Results and Annual Report 2021
8th Apr 20227:00 amRNSTanzania Operations Update
1st Apr 20224:41 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
1st Apr 202211:09 amRNSSuccessful Placing to Fund Aminex to First Gas
28th Mar 20222:05 pmRNSSecond Price Monitoring Extn
28th Mar 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.